Ascendis Pharma ASMEX:ASNDN 37 FCF Yield % is 0.46 as of Jun. 25, 2026, which is 4% below its 10-year median of 0.48. GuruFocus rates MEX:ASNDN with a GF Score™ of 37/100. The stock has 1 warning sign investors should review. Among 1,418 Biotechnology companies, Ascendis Pharma AS ranks better than 84.56% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Ascendis Pharma AS FCF Yield % Related Terms
Ascendis Pharma AS FCF Yield % Historical Data
* Premium members only.
The historical data trend for Ascendis Pharma AS's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:ASNDN vs SMMT, BBIO, JAZZ: FCF Yield % Comparison
For the Biotechnology subindustry, Ascendis Pharma AS's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ascendis Pharma AS FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ascendis Pharma AS's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Ascendis Pharma AS's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ascendis Pharma AS (MEX:ASNDN) has a FCF Yield % of 0.46 as of Jun. 25, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Ascendis Pharma AS and its competitors. This is near median its historical median of 0.48. Over the past decade, Ascendis Pharma AS's FCF Yield % has ranged from 0.45 to 0.52. According to the industry distribution chart, Ascendis Pharma AS ranks #219 out of 1418 companies in the Biotechnology industry, placing it in the top 15.4%.
Is Ascendis Pharma AS's FCF Yield % too high?
Ascendis Pharma AS's current FCF Yield % of 0.46 is near median its 10-year median of 0.48. Over the past 10 years, this metric has ranged from a low of 0.45 to a high of 0.52. Based on the distribution chart, Ascendis Pharma AS ranks #219 out of 1418 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Ascendis Pharma AS has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Ascendis Pharma AS's FCF Yield % compare to SMMT and BBIO?
According to the Biotechnology industry distribution chart, Ascendis Pharma AS ranks #219 out of 1418 companies for FCF Yield %. This places Ascendis Pharma AS in the top 15% of its industry — outperforming the majority of peers. Historically, Ascendis Pharma AS's own FCF Yield % has ranged from 0.45 to 0.52 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Ascendis Pharma AS and its competitors. Ascendis Pharma AS's current FCF Yield % is 0.46, which is near median its own 10-year median of 0.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascendis Pharma AS stock overvalued right now?
Ascendis Pharma AS (MEX:ASNDN) has a current FCF Yield % of 0.46. The current FCF Yield % is 0.46, which is near median its 10-year median of 0.48. Ascendis Pharma AS's overall GF Score™ is 37/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Ascendis Pharma AS (MEX:ASNDN), the current FCF Yield % is 0.46 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
37GF Score
Get the complete analysis for MEX:ASNDN
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ASNDN has been successfully added to your 
